These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
4. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
5. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. Keidar Z; Engel A; Hoffman A; Israel O; Nitecki S J Nucl Med; 2007 Aug; 48(8):1230-6. PubMed ID: 17631553 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248 [TBL] [Abstract][Full Text] [Related]
8. Utility of 18F-FDG-PET/CT imaging in the diagnosis of appendicitis. Moghadam-Kia S; Nawaz A; Newberg A; Basu S; Alavi A; Torigian DA Hell J Nucl Med; 2009; 12(3):281-2. PubMed ID: 19936346 [No Abstract] [Full Text] [Related]
9. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer. Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406 [TBL] [Abstract][Full Text] [Related]
10. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439 [TBL] [Abstract][Full Text] [Related]
11. Fever of unknown origin: the role of 18F-FDG PET/CT. Keidar Z; Gurman-Balbir A; Gaitini D; Israel O J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040 [TBL] [Abstract][Full Text] [Related]
12. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography. Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181 [TBL] [Abstract][Full Text] [Related]
13. Incidental inflammatory findings in nerves and in patients with neoplastic diseases evaluated by 18F-FDG-PET/CT. Bertagna F; Giubbini R; Biasiotto G; Rosenbaum J; Alavi A Hell J Nucl Med; 2009; 12(3):279-80. PubMed ID: 19936345 [No Abstract] [Full Text] [Related]
14. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443 [TBL] [Abstract][Full Text] [Related]
15. 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma. Watanabe S; Yano F; Kita T; Soga S; Shinmoto H; Kosuda S; Ozeki Y; Aida S; Sakata I Ann Nucl Med; 2008 Jul; 22(6):521-4. PubMed ID: 18670859 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients. Saif MW; Cornfeld D; Modarresifar H; Ojha B J Gastrointestin Liver Dis; 2008 Jun; 17(2):173-8. PubMed ID: 18568138 [TBL] [Abstract][Full Text] [Related]
17. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Gordin A; Golz A; Keidar Z; Daitzchman M; Bar-Shalom R; Israel O Otolaryngol Head Neck Surg; 2007 Jul; 137(1):130-7. PubMed ID: 17599580 [TBL] [Abstract][Full Text] [Related]
18. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development. Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761 [TBL] [Abstract][Full Text] [Related]
19. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Zimmer LA; Branstetter BF; Nayak JV; Johnson JT Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618 [TBL] [Abstract][Full Text] [Related]
20. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Balink H; Collins J; Bruyn GA; Gemmel F Clin Nucl Med; 2009 Dec; 34(12):862-8. PubMed ID: 20139818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]